Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Yang X, Yan J, Feng J
Eur J Pharmacol. 2015 Dec 10; 771:18-28. PMID: 26683637.Abstract